Trend Reversal (Poss.) - Weekly Interval - EVFM
Hello Successful Traders,
The stock (EVFM) manifested a strong positive (bullish) sentiment for the beginning period of May. Considering the heightened volume spike, quarterly earnings exceed expectations (Y/Y), technical trend lines presenting strong consolidation (for greater strength in upward penetration), and as well as numerous other implications (BB, Overall-Trend, etc.)
Resistance Level 2 - (16.95 - 17.75) 80 cent interval
Resistance Level 1 - (8.25 - 9.00) 75 cent interval
Key Price Zone (KPZ) - (3.50 - 4.25) 75 cent interval
Support Level 1 - (1.50 - 2.25) 75 cent interval
Furthermore, there could be a false penetration upward (as numerous fundamental analytics manifest worrisome growth for the bio-pharmaceutical's overall performance)
Not Investment Advice. For Educational and Analytical Purposes Only. (Be Diligent and Stick To Your Trading Plan)***
-LionGate
The stock (EVFM) manifested a strong positive (bullish) sentiment for the beginning period of May. Considering the heightened volume spike, quarterly earnings exceed expectations (Y/Y), technical trend lines presenting strong consolidation (for greater strength in upward penetration), and as well as numerous other implications (BB, Overall-Trend, etc.)
Resistance Level 2 - (16.95 - 17.75) 80 cent interval
Resistance Level 1 - (8.25 - 9.00) 75 cent interval
Key Price Zone (KPZ) - (3.50 - 4.25) 75 cent interval
Support Level 1 - (1.50 - 2.25) 75 cent interval
Furthermore, there could be a false penetration upward (as numerous fundamental analytics manifest worrisome growth for the bio-pharmaceutical's overall performance)
Not Investment Advice. For Educational and Analytical Purposes Only. (Be Diligent and Stick To Your Trading Plan)***
-LionGate
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.